Alaunos Therapeutics settles unpaid invoices with MD Anderson for $285,055

Alaunos Therapeutics, Inc.

Settlement resolves disputes over $285,055 in unpaid invoices under 2019 R&D agreement with MD Anderson.
Alaunos to pay in six installments: $142,528 by Dec 30, 2025, then five monthly payments of $28,506 through May 30, 2026.
Mutual general releases exchanged for claims related to unpaid invoices; ongoing protocol 2006-0676 excluded.
CEO Holger Weis signed agreement on Dec 15, 2025; effective date Dec 17, 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.